First Turn Management »

Immunocore Holdings Plc- shares owned by First Turn Management

Quarter-by-quarter ownership of Immunocore Holdings Plc- (IMCR) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Immunocore Holdings Plc-

Tip: Access up to 7 years of quarterly data

All positions including Immunocore Holdings Plc- held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunocore Holdings Plc- by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $23M 343k 68.32

More positions owned by First Turn Management

Cytokinetics Com New (CYTK)
Cymabay Therapeutics
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Krystal Biotech (KRYS)
Legend Biotech Corp Sponsored Ads (LEGN)
Karuna Therapeutics Ord
Transmedics Group (TMDX)
Insulet Corporation (PODD)
Day One Biopharmaceuticals I (DAWN)
Mirum Pharmaceuticals (MIRM)
Verona Pharma Sponsored Ads (VRNA)
Dex (DXCM)
Axsome Therapeutics (AXSM)

View all positions for First Turn Management

Top funds holding Immunocore Holdings Plc-

Wellington Management Company
T. Rowe Price Associates
Baker Bros. Advisors
Paradigm Biocapital Advisors
Bellevue Group
Fiera Capital Corporation
Braidwell
Bill & Melinda Gates Foundation
Cowen And Company
Principal Financial Group
Tang Capital Management
Logos Global Management
TD Asset Management
First Turn Management
Massachusetts Financial Services

View all funds holding Immunocore Holdings Plc-